RxDoctor Payments Data

Angela Schuff, DPM

Podiatrist · Oklahoma City, OKNPI 1407816457

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 90.7% of the total across 116 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 32 manufacturers reported payments, led by Stryker at 31.7% of the total.

$4,365in general payments, 2019–2025

Across 116 payments — averaging $37.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$1K
  • Medtronic$330
  • Musculoskeletal Transplant Foundation Inc.$307
  • Organogenesis Inc.$299
  • Zimmer Biomet$237
  • Paratek Pharmaceuticals, Inc.$236
  • plus $2K from 26 others

What the payments were for

  • Consulting fees$1002%
  • Travel & lodging$3077%
  • Food & beverage$3,95991%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,365 in reported general payments places this provider in the 75th percentile of 54 podiatrist providers in Oklahoma.

See all podiatrist providers in Oklahoma

Medicare billing

Part B allowed, 2024
$159,768
Medicare patients
659
Services billed
1,937

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Diclofenac Sodium ErDiclofenac Sodium72$2,314
Terbinafine Hcl40$1,171
Clobetasol Propionate15$720
Colchicine14$335
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen33$330
Allopurinol54$231
Ondansetron OdtOndansetron36$173
Cephalexin21$167
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav14$128
Acetaminophen-CodeineAcetaminophen With Codeine11$54
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim12$37
Tramadol Hcl14$33

Paid to pharmacies, not to this prescriber.

Other podiatrist in Oklahoma City

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →